SolarWindow (WNDW) 10-Q 14 Jan 25 2025 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Nov. 30, 2024	Jan. 13, 2025
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Nov. 30, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--08-31
Entity File Number	333-127953
Entity Registrant Name	SOLARWINDOW TECHNOLOGIES, INC.
Entity Central Index Key	0001071840
Entity Tax Identification Number	59-3509694
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	9375 E. Shea Blvd.
Entity Address, Address Line Two	Suite 107-B
Entity Address, City or Town	Scottsdale
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85260
City Area Code	(800)
Local Phone Number	213-0689
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		53,198,399

CONSOLIDATED BALANCE SHEETS (UN

CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Nov. 30, 2024	Aug. 31, 2024
Current assets
Cash and cash equivalents	$ 721,879	$ 1,249,446
Short-term investments	3,000,000	3,000,000
Deferred research and development costs	42,141	45,706
Prepaid expenses and other current assets	755,571	681,529
Current assets of discontinued operations	12,899	13,489
Total current assets	4,532,490	4,990,170
Property and Equipment, net	11,813	13,458
Total assets	4,544,303	5,003,628
Current liabilities
Accounts payable and accrued expenses	95,196	85,922
Related party payables	158,745	113,120
Current liabilities of discontinued operations	106,445	122,470
Total current liabilities	360,386	321,512
Total liabilities	360,386	321,512
Stockholders' equity
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding
Common stock: $0.001 par value; 300,000,000 shares authorized, 53,198,399 shares issued and outstanding at November 30, 2024 and August 31, 2024	53,198	53,198
Additional paid-in capital	83,590,467	83,538,904
Accumulated other comprehensive loss	(74,401)	(76,702)
Accumulated deficit	(79,385,347)	(78,833,284)
Total stockholders' equity	4,183,917	4,682,116
Total liabilities and stockholders' equity	$ 4,544,303	$ 5,003,628

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Nov. 30, 2024	Aug. 31, 2024
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.10	$ 0.10
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	53,198,399	53,198,399
Common stock, shares outstanding	53,198,399	53,198,399

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Income Statement [Abstract]
Revenue
Operating expenses:
Selling, general and administrative	457,952	451,501
Research and development	137,179	116,696
Total operating expenses	595,131	568,197
Loss from operations	(595,131)	(568,197)
Other income:
Interest income	44,039	68,695
Total other income	44,039	68,695
Net loss from continuing operations	(551,092)	(499,502)
Net loss from discontinued operations	(971)	(1,870)
Net loss attributable to common stockholders	(552,063)	(501,372)
Other comprehensive income (loss):
Foreign currency translation gain/(loss)	2,301	(1,528)
Comprehensive (loss) attributable to common stockholders’	$ (549,762)	$ (502,900)
Loss per Share from continuing operations basic	$ (0.01)	$ (0.01)
Loss per Share from continuing operations diluted	(0.01)	(0.01)
Loss per Share from discontinued operations basic	0	0
Loss per Share from discontinued operations diluted	0	0
Loss per Share basic	(0.01)	(0.01)
Loss per Share diluted	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding - basic	53,198,399	53,198,399
Weighted average number of common shares outstanding - diluted	53,198,399	53,198,399

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Aug. 31, 2023	$ 53,198	$ 82,735,384	$ (78,159)	$ (75,377,869)	$ 7,332,554
Beginning balance, shares at Aug. 31, 2023	53,198,399
Stock based compensation due to common stock purchase options		23,215			23,215
Foreign currency translation adjustment			(1,528)		(1,528)
Net loss				(501,372)	(501,372)
Ending balance, value at Nov. 30, 2023	$ 53,198	82,758,599	(79,687)	(75,879,241)	6,852,869
Ending balance, shares at Nov. 30, 2023	53,198,399
Beginning balance, value at Aug. 31, 2024	$ 53,198	83,538,904	(76,702)	(78,833,284)	4,682,116
Beginning balance, shares at Aug. 31, 2024	53,198,399
Stock based compensation due to common stock purchase options		51,563			51,563
Foreign currency translation adjustment			2,301		2,301
Net loss				(552,063)	(552,063)
Ending balance, value at Nov. 30, 2024	$ 53,198	$ 83,590,467	$ (74,401)	$ (79,385,347)	$ 4,183,917
Ending balance, shares at Nov. 30, 2024	53,198,399

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Cash flows from operating activities
Net loss from continuing operations	$ (551,092)	$ (499,502)
Net loss from discontinued operations	(971)	(1,870)
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation	1,645	3,594
Stock based compensation expense	51,563	23,215
Changes in operating assets and liabilities:
Deferred research and development costs	3,565	(46,935)
Prepaid expenses and other assets	(74,042)	(78,650)
Accounts payable and accrued expenses	(3,860)	55,000
Related party payable	45,625	(12,442)
Net cash used in operating activities	(527,567)	(557,590)
Cash flows from investing activities
Redemption of short-term investments		200,000
Net cash provided by investing activities		200,000
Net decrease in cash and cash equivalents	(527,567)	(357,590)
Cash  and cash equivalents at beginning of period	1,249,446	492,610
Cash and cash equivalents at end of period	$ 721,879	$ 135,020

Organization

Organization	3 Months Ended
	Nov. 30, 2024
Accounting Policies [Abstract]
Organization	NOTE 1 – Organization Organization SolarWindow Technologies, Inc. was incorporated in the State of Nevada on May 5, 1998 (“ SWT Company OPV On August 24, 2020, SolarWindow Technologies, Inc. formed wholly owned SolarWindow Asia (USA) Corp., a Nevada Corporation, as the holding company for SolarWindow Asia Co. Ltd., (the “ Korean Subsidiary Liquidity The Company has not generated any revenue since inception and has sustained recurring losses and negative cash flows from operations since inception. We expect to incur losses as we continue to develop and further refine and promote our technologies and potential product applications. As of November 30, 2024, the Company had $ 3,721,879 4,172,104

Interim Statement Presentation

Interim Statement Presentation	3 Months Ended
	Nov. 30, 2024
Interim Statement Presentation
Interim Statement Presentation	NOTE 2 – Interim Statement Presentation Basis of Presentation and Use of Estimates The accompanying unaudited interim consolidated financial statements of the Company as of November 30, 2024, and for the three months ended November 30, 2024 and 2023 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“ SEC U.S. GAAP The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying disclosures. Actual results may differ from those estimates. The accompanying unaudited interim consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s consolidated financial position as of November 30, 2024, results of operations, stockholders’ equity and cash flows for the three months ended November 30, 2024 and 2023. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year. The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. The Company considers its accounting policies relating to the impairment of long-lived assets and stock-based compensation to be the most significant accounting policy that involves management estimates and judgments. The Company has made accounting estimates based on the facts and circumstances available as of the reporting date. Actual amounts could differ from these estimates, and such differences could be material. These consolidated financial statements presented are those of SWT and its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and the Korean Subsidiary. All significant intercompany balances and transactions have been eliminated. As more fully described in Note 3, on January 13, 2023, the Board determined that it is in the best interests of the Company to discontinue operations in South Korea and to dissolve the Korean Subsidiary. In accordance with applicable accounting guidance, the results of the Korean Subsidiary are presented as discontinued operations in the Consolidated Statements of Operations and Comprehensive Loss and, as such, have been excluded from continuing operations. The Consolidated Statements of Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2024. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Financial Statements” in the Annual Report. Fiscal quarter The Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s first quarter in fiscal 2025 and 2024 ended on November 30, 2024 and 2023, respectively. Cash and Cash Equivalents and Short-Term Investments Cash includes cash on hand and short-term investments with original maturities of three months or less from the date of purchase. The Company had $ 3,721,879 45,903 3,675,895 3,604,517 Cash and cash equivalents and short-term investments include the following: Schedule of cash and cash equivalents and short-term investments November 30, August 31, 2024 2024 Cash $ 721,879 $ 1,249,446 Short-term investments 3,000,000 3,000,000 Total cash and short-term investments $ 3,721,879 $ 4,249,446 Short-term investments The Company determines the balance sheet classification of its investments at the time of purchase and evaluates the classification at each balance sheet date. Money market funds, certificates of deposit, and time deposits with maturities of greater than three months but no more than twelve months are carried at cost, which approximates fair value and are recorded in the consolidated balance sheets in short-term investments. Time Deposits typically pay earned interest at the time of maturity or redemption. During the three months ended November 30, 2024 and 2023, $0 and $200,000 of time were redeemed, respectively. During the three months ended November 30, 2024 and 2023, the Company received $65,534 and $5,915, respectively, of earned interest on its time deposits. On February 28, 2024, the Company purchased new time deposits, which consist of a 12-month $2,500,000 fixed-term deposit earning interest of 5.2%, and a 12-month $500,000 fixed-term deposit earning interest of 4.50%. During the three months ended November 30, 2024 and 2023, the Company recognized interest income related to short-term investment of $38,020 and $67,957, respectively. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets includes the following items: Schedule of prepaid expenses and other current assets November 30, August 31, 2024 2024 Prepaid expenses $ 20,000 $ 8,000 Prepaid insurance premium (a) 99,167 9,612 Interest income receivable (b) 27,699 55,212 Equipment deposit refund receivable (c) 608,705 608,705 Total $ 755,571 $ 681,529 (a) Relates to prepaid premium on the Company’s Directors and Officers liability insurance (b) Relates to interest receivable in short term deposits as described above under NOTE 2 – Interim Statement Presentation, “Short-term Investments.” (c) For additional information, see NOTE 5 – Property and Equipment Accounting Pronouncements The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company’s previous fiscal year may be applicable, the Company has not identified any standards that the Company believes merit further discussion. Recent accounting pronouncements not yet adopted None. Recently adopted accounting pronouncements In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, “ Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

Discontinued Operations

Discontinued Operations	3 Months Ended
	Nov. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	NOTE 3 – Discontinued Operations On January 13, 2023, the Board determined that it is in the best interests of the Company to discontinue operations in South Korea and to dissolve the Korean Subsidiary. The Company is working to dispose the Korean Subsidiary other than by sale in accordance with Accounting Standards Codification (“ASC”) 360-10-45-15, Long-Lived Assets to Be Disposed of Other Than by Sale. In accordance with ASC 205-20, Discontinued Operations, the results of the Korean Subsidiary are presented as discontinued operations in the Consolidated Statements of Operations and Comprehensive Loss, and, as such, have been excluded from continuing operations. The Consolidated Statements of Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. The following table summarizes the significant items included in income from discontinued operations, net of tax in the Consolidated Statement of Operations and Comprehensive Loss for the three months ended November 30, 2024 and 2023: Schedule of statement of operations and comprehensive loss Three Months Ended November 30, 2024 2023 Operating expenses Selling, general and administrative $ 971 $ 1,870 Total operating expenses 971 1,870 Net loss from discontinued operations $ (971 ) $ (1,870 ) The following table summarizes the carrying value of the significant classes of assets and liabilities classified as discontinued operations as of November 30, 2024 and August 31, 2024: Schedule of significant classes of assets and liabilities November 30, 2024 August 31, 2024 Current assets Prepaid expenses and other current assets $ 12,899 $ 13,489 Total current assets 12,899 13,489 Total assets $ 12,899 $ 13,489 Current liabilities Accounts payable and accrued expenses $ 106,445 $ 122,470 Total current liabilities $ 106,445 $ 122,470

Net Income (Loss) Per Share

Net Income (Loss) Per Share	3 Months Ended
	Nov. 30, 2024
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	NOTE 4 - Net Income (Loss) Per Share The computation of basic earnings per share (“ EPS The shares listed below were not included in the computation of diluted losses per share because to do so would be antidilutive for the periods presented: Schedule of computation of diluted losses per share For the Three Months Ended November 30, 2024 2023 Stock options 5,433,000 4,183,000 Warrants 16,666,667 16,666,667 22,099,667 20,849,667

Property and Equipment

Property and Equipment	3 Months Ended
	Nov. 30, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	NOTE 5 – Property and Equipment Property and equipment consists of the following: Schedule of property and equipment November 30, August 31, 2024 2024 Computers, office equipment and software $ 16,051 $ 16,051 Equipment 133,653 133,653 Total property and equipment 149,704 149,704 Accumulated depreciation (137,891 ) (136,246 ) Property and equipment, net $ 11,813 $ 13,458 During the three months ended November 30, 2024 and 2023, the Company recognized straight-line depreciation expense of $ 1,645 3,594 During the year ended August 31, 2019, the Company made deposits for in-process equipment totaling $ 1,292,655 608,705 683,950 210,000 473,950

Common Stock and Warrants

Common Stock and Warrants	3 Months Ended
	Nov. 30, 2024
Equity [Abstract]
Common Stock and Warrants	NOTE 6 – Common Stock and Warrants Common Stock At November 30, 2024, the Company had 300,000,000 0.001 53,198,399 Warrants Each of the Company’s warrants outstanding entitles the holder to purchase one share of the Company’s common stock for each warrant share held. The following warrants may be exercised on a cashless basis. A summary of the Company’s warrants outstanding and exercisable as of November 30, 2024 and August 31, 2024 is as follows: Schedule of warrants outstanding and exercisable Shares of Common Stock Weighted November 30, August 31, Exercise Description 2024 2024 Price Date of Issuance Expiration Series T 16,666,667 16,666,667 $ 1.70 November 26, 2018 November 26, 2029

Stock Options

Stock Options	3 Months Ended
	Nov. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock Options	NOTE 7 - Stock Options The Company measures share-based compensation cost on the grant date, based on the fair value of the award, and recognizes the expense on a straight-line basis over the requisite service period for awards expected to vest. The Company estimates the grant date fair value of stock options using a Black-Scholes valuation model. No stock options were granted during the three months ended November 30, 2024 and 2023. A summary of the Company’s stock option activity for the nine months ended May 31, 2024 and related information follows: Schedule of stock option activity Number of Weighted Weighted Aggregate Outstanding at August 31, 2024 5,433,000 2.41 Outstanding at November 30, 2024 5,433,000 2.41 4.39 - Exercisable at November 30, 2024 4,808,000 2.68 4.35 - The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their vested options on November 30, 2024. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $ 0.32 0.32 no The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three months ended November 30 Schedule of share-based compensation Three Months Ended November 30, 2024 2023 Stock compensation expense: Selling, general and administrative $ 51,563 $ 22,510 Research and development - 705 Total $ 51,563 $ 23,215 As of November 30 51,563 The following table summarizes information about stock options outstanding and exercisable at November 30 Schedule of stock options outstanding and exercisable Stock Options Outstanding Stock Options Exercisable Range of Exercise Prices Number of Shares Subject to Outstanding Options Weighted Average Contractual Life (years) Weighted Average Exercise Price ($) Number of Shares Subject To Options Exercise Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price ($) 0.33 1,250,000 4.36 0.33 625,000 4.36 0.33 2.32 153,000 4.86 2.32 153,000 4.86 2.32 2.60 2,500,000 4.19 2.60 2,500,000 4.19 2.60 3.42 50,000 1.88 3.42 50,000 1.88 3.42 3.46 35,000 1.10 3.46 35,000 1.10 3.46 3.54 1,225,000 3.62 3.54 1,225,000 3.62 3.54 4.87 110,000 3.97 4.87 110,000 3.97 4.87 6.21 110,000 6.91 6.21 110,000 6.91 6.21 Total 5,433,000 4.39 2.41 4,808,000 4.35 2.68

Transactions with Related Perso

Transactions with Related Persons	3 Months Ended
	Nov. 30, 2024
Related Party Transactions [Abstract]
Transactions with Related Persons	NOTE 8 - Transactions with Related Persons A related party with respect to the Company is generally defined as any person (and, if a natural person, inclusive of his or her immediate family) (i) that holds 10% or more of the Company’s securities, (ii) that is part of the Company’s management, (iii) that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Joseph Sierchio, one of the Company’s directors, has maintained his role as the Company’s general counsel since its inception, and, beginning in August 2020, as Principal of Sierchio Law, LLP pursuant to an engagement letter which provided for an annual fee of $ 175,000 61,700 43,750 64,200 61,700 2,500 All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Nov. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 9 – Commitments and Contingencies On June 9, 2022, the Company was served the Notice of Civil Claim dated May 16, 2022 (the “ Notice of Claim Application Order

Subsequent Events

Subsequent Events	3 Months Ended
	Nov. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	NOTE 10 – Subsequent Events Management has reviewed material events subsequent of the period ended November 30, 2024 and through the date of filing of financial statements in accordance with FASB ASC 855 “Subsequent Events”. In managements opinion, no material subsequent events have occurred as of the date of this quarterly report.

Interim Statement Presentation

Interim Statement Presentation (Policies)	3 Months Ended
	Nov. 30, 2024
Interim Statement Presentation
Basis of Presentation and Use of Estimates	Basis of Presentation and Use of Estimates The accompanying unaudited interim consolidated financial statements of the Company as of November 30, 2024, and for the three months ended November 30, 2024 and 2023 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“ SEC U.S. GAAP The accompanying unaudited interim consolidated financial statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying disclosures. Actual results may differ from those estimates. The accompanying unaudited interim consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments (including normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s consolidated financial position as of November 30, 2024, results of operations, stockholders’ equity and cash flows for the three months ended November 30, 2024 and 2023. The Company did not record an income tax provision during the periods presented due to net taxable losses. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year. The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. The Company considers its accounting policies relating to the impairment of long-lived assets and stock-based compensation to be the most significant accounting policy that involves management estimates and judgments. The Company has made accounting estimates based on the facts and circumstances available as of the reporting date. Actual amounts could differ from these estimates, and such differences could be material. These consolidated financial statements presented are those of SWT and its wholly owned subsidiaries, SolarWindow Asia (USA) Corp., and the Korean Subsidiary. All significant intercompany balances and transactions have been eliminated. As more fully described in Note 3, on January 13, 2023, the Board determined that it is in the best interests of the Company to discontinue operations in South Korea and to dissolve the Korean Subsidiary. In accordance with applicable accounting guidance, the results of the Korean Subsidiary are presented as discontinued operations in the Consolidated Statements of Operations and Comprehensive Loss and, as such, have been excluded from continuing operations. The Consolidated Statements of Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended August 31, 2024. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Financial Statements” in the Annual Report.
Fiscal quarter	Fiscal quarter The Company’s quarterly periods end on November 30, February 28, May 31, and August 31. The Company’s first quarter in fiscal 2025 and 2024 ended on November 30, 2024 and 2023, respectively.
Cash and Cash Equivalents and Short-Term Investments	Cash and Cash Equivalents and Short-Term Investments Cash includes cash on hand and short-term investments with original maturities of three months or less from the date of purchase. The Company had $ 3,721,879 45,903 3,675,895 3,604,517 Cash and cash equivalents and short-term investments include the following: Schedule of cash and cash equivalents and short-term investments November 30, August 31, 2024 2024 Cash $ 721,879 $ 1,249,446 Short-term investments 3,000,000 3,000,000 Total cash and short-term investments $ 3,721,879 $ 4,249,446
Short-term investments	Short-term investments The Company determines the balance sheet classification of its investments at the time of purchase and evaluates the classification at each balance sheet date. Money market funds, certificates of deposit, and time deposits with maturities of greater than three months but no more than twelve months are carried at cost, which approximates fair value and are recorded in the consolidated balance sheets in short-term investments. Time Deposits typically pay earned interest at the time of maturity or redemption. During the three months ended November 30, 2024 and 2023, $0 and $200,000 of time were redeemed, respectively. During the three months ended November 30, 2024 and 2023, the Company received $65,534 and $5,915, respectively, of earned interest on its time deposits. On February 28, 2024, the Company purchased new time deposits, which consist of a 12-month $2,500,000 fixed-term deposit earning interest of 5.2%, and a 12-month $500,000 fixed-term deposit earning interest of 4.50%. During the three months ended November 30, 2024 and 2023, the Company recognized interest income related to short-term investment of $38,020 and $67,957, respectively.
Prepaid Expenses and Other Current Assets	Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets includes the following items: Schedule of prepaid expenses and other current assets November 30, August 31, 2024 2024 Prepaid expenses $ 20,000 $ 8,000 Prepaid insurance premium (a) 99,167 9,612 Interest income receivable (b) 27,699 55,212 Equipment deposit refund receivable (c) 608,705 608,705 Total $ 755,571 $ 681,529 (a) Relates to prepaid premium on the Company’s Directors and Officers liability insurance (b) Relates to interest receivable in short term deposits as described above under NOTE 2 – Interim Statement Presentation, “Short-term Investments.” (c) For additional information, see NOTE 5 – Property and Equipment
Accounting Pronouncements	Accounting Pronouncements The Company reviews new accounting standards as issued. Although some of these accounting standards issued or effective after the end of the Company’s previous fiscal year may be applicable, the Company has not identified any standards that the Company believes merit further discussion. Recent accounting pronouncements not yet adopted None. Recently adopted accounting pronouncements In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, “ Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

Interim Statement Presentatio_2

Interim Statement Presentation (Tables)	3 Months Ended
	Nov. 30, 2024
Interim Statement Presentation
Schedule of cash and cash equivalents and short-term investments	Schedule of cash and cash equivalents and short-term investments November 30, August 31, 2024 2024 Cash $ 721,879 $ 1,249,446 Short-term investments 3,000,000 3,000,000 Total cash and short-term investments $ 3,721,879 $ 4,249,446
Schedule of prepaid expenses and other current assets	Schedule of prepaid expenses and other current assets November 30, August 31, 2024 2024 Prepaid expenses $ 20,000 $ 8,000 Prepaid insurance premium (a) 99,167 9,612 Interest income receivable (b) 27,699 55,212 Equipment deposit refund receivable (c) 608,705 608,705 Total $ 755,571 $ 681,529 (a) Relates to prepaid premium on the Company’s Directors and Officers liability insurance (b) Relates to interest receivable in short term deposits as described above under NOTE 2 – Interim Statement Presentation, “Short-term Investments.” (c) For additional information, see NOTE 5 – Property and Equipment

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Nov. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of statement of operations and comprehensive loss	Schedule of statement of operations and comprehensive loss Three Months Ended November 30, 2024 2023 Operating expenses Selling, general and administrative $ 971 $ 1,870 Total operating expenses 971 1,870 Net loss from discontinued operations $ (971 ) $ (1,870 )
Schedule of significant classes of assets and liabilities	Schedule of significant classes of assets and liabilities November 30, 2024 August 31, 2024 Current assets Prepaid expenses and other current assets $ 12,899 $ 13,489 Total current assets 12,899 13,489 Total assets $ 12,899 $ 13,489 Current liabilities Accounts payable and accrued expenses $ 106,445 $ 122,470 Total current liabilities $ 106,445 $ 122,470

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	3 Months Ended
	Nov. 30, 2024
Earnings Per Share [Abstract]
Schedule of computation of diluted losses per share	Schedule of computation of diluted losses per share For the Three Months Ended November 30, 2024 2023 Stock options 5,433,000 4,183,000 Warrants 16,666,667 16,666,667 22,099,667 20,849,667

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Nov. 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Schedule of property and equipment November 30, August 31, 2024 2024 Computers, office equipment and software $ 16,051 $ 16,051 Equipment 133,653 133,653 Total property and equipment 149,704 149,704 Accumulated depreciation (137,891 ) (136,246 ) Property and equipment, net $ 11,813 $ 13,458

Common Stock and Warrants (Tabl

Common Stock and Warrants (Tables)	3 Months Ended
	Nov. 30, 2024
Equity [Abstract]
Schedule of warrants outstanding and exercisable	Schedule of warrants outstanding and exercisable Shares of Common Stock Weighted November 30, August 31, Exercise Description 2024 2024 Price Date of Issuance Expiration Series T 16,666,667 16,666,667 $ 1.70 November 26, 2018 November 26, 2029

Stock Options (Tables)

Stock Options (Tables)	3 Months Ended
	Nov. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of stock option activity	Schedule of stock option activity Number of Weighted Weighted Aggregate Outstanding at August 31, 2024 5,433,000 2.41 Outstanding at November 30, 2024 5,433,000 2.41 4.39 - Exercisable at November 30, 2024 4,808,000 2.68 4.35 -
Schedule of share-based compensation	Schedule of share-based compensation Three Months Ended November 30, 2024 2023 Stock compensation expense: Selling, general and administrative $ 51,563 $ 22,510 Research and development - 705 Total $ 51,563 $ 23,215
Schedule of stock options outstanding and exercisable	Schedule of stock options outstanding and exercisable Stock Options Outstanding Stock Options Exercisable Range of Exercise Prices Number of Shares Subject to Outstanding Options Weighted Average Contractual Life (years) Weighted Average Exercise Price ($) Number of Shares Subject To Options Exercise Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price ($) 0.33 1,250,000 4.36 0.33 625,000 4.36 0.33 2.32 153,000 4.86 2.32 153,000 4.86 2.32 2.60 2,500,000 4.19 2.60 2,500,000 4.19 2.60 3.42 50,000 1.88 3.42 50,000 1.88 3.42 3.46 35,000 1.10 3.46 35,000 1.10 3.46 3.54 1,225,000 3.62 3.54 1,225,000 3.62 3.54 4.87 110,000 3.97 4.87 110,000 3.97 4.87 6.21 110,000 6.91 6.21 110,000 6.91 6.21 Total 5,433,000 4.39 2.41 4,808,000 4.35 2.68

Organization (Details Narrative

Organization (Details Narrative) - USD ($)	Nov. 30, 2024	Aug. 31, 2024
Accounting Policies [Abstract]
Cash, cash equivalents and short-term investments	$ 3,721,879	$ 4,249,446
Working capital	$ 4,172,104

Interim Statement Presentatio_3

Interim Statement Presentation (Details) - USD ($)	Nov. 30, 2024	Aug. 31, 2024
Interim Statement Presentation
Cash	$ 721,879	$ 1,249,446
Short-term investments	3,000,000	3,000,000
Total cash and short-term investments	$ 3,721,879	$ 4,249,446

Interim Statement Presentatio_4

Interim Statement Presentation (Details 1) - USD ($)		Nov. 30, 2024	Aug. 31, 2024
Interim Statement Presentation
Prepaid expenses		$ 20,000	$ 8,000
Prepaid insurance premium	[1]	99,167	9,612
Interest income receivable	[2]	27,699	55,212
Equipment deposit refund receivable	[3]	608,705	608,705
Total		$ 755,571	$ 681,529
[1]Relates to prepaid premium on the Company’s Directors and Officers liability insurance[2]Relates to interest receivable in short term deposits as described above under NOTE 2 – Interim Statement Presentation, “Short-term Investments.”[3]For additional information, see NOTE 5 – Property and Equipment

Interim Statement Presentatio_5

Interim Statement Presentation (Details Narrative) - USD ($)	3 Months Ended
	Nov. 30, 2024	Aug. 31, 2024
Schedule of Investments [Line Items]
Cash held in investments	$ 721,879	$ 1,249,446
Short term investment description	During the three months ended November 30, 2024 and 2023, $0 and $200,000 of time were redeemed, respectively. During the three months ended November 30, 2024 and 2023, the Company received $65,534 and $5,915, respectively, of earned interest on its time deposits. On February 28, 2024, the Company purchased new time deposits, which consist of a 12-month $2,500,000 fixed-term deposit earning interest of 5.2%, and a 12-month $500,000 fixed-term deposit earning interest of 4.50%. During the three months ended November 30, 2024 and 2023, the Company recognized interest income related to short-term investment of $38,020 and $67,957, respectively.
US Investments [Member]
Schedule of Investments [Line Items]
Cash held in investments	$ 3,721,879
FDIC insured amount	45,903
Canadian Bank [Member]
Schedule of Investments [Line Items]
Cash held in investments	3,675,895
FDIC insured amount	$ 3,604,517

Discontinued Operations (Detail

Discontinued Operations (Details) - USD ($)	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Operating expenses
Selling, general and administrative	$ 971	$ 1,870
Total operating expenses	971	1,870
Net loss from discontinued operations	$ (971)	$ (1,870)

Discontinued Operations (Deta_2

Discontinued Operations (Details 1) - USD ($)	Nov. 30, 2024	Aug. 31, 2024
Current assets
Prepaid expenses and other current assets	$ 12,899	$ 13,489
Total current assets	12,899	13,489
Total assets	12,899	13,489
Current liabilities
Accounts payable and accrued expenses	106,445	122,470
Total current liabilities	$ 106,445	$ 122,470

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - shares	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	22,099,667	20,849,667
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	5,433,000	4,183,000
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	16,666,667	16,666,667

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Nov. 30, 2024	Aug. 31, 2024
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 149,704	$ 149,704
Accumulated depreciation	(137,891)	(136,246)
Property and equipment, net	11,813	13,458
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	16,051	16,051
Equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 133,653	$ 133,653

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)		3 Months Ended
	Jun. 01, 2024	Nov. 30, 2024	Nov. 30, 2023	Aug. 31, 2024	Aug. 31, 2019
Property, Plant and Equipment [Line Items]
Depreciation expense		$ 1,645	$ 3,594
Deposits for in-process equipment		$ 149,704		$ 149,704
Unallocated to current assets	$ 608,705
Impaired long lived asset	683,950
Coating die valued	210,000
Engineering design valued	$ 473,950
In Process Equipments [Member]
Property, Plant and Equipment [Line Items]
Deposits for in-process equipment					$ 1,292,655

Common Stock and Warrants (Deta

Common Stock and Warrants (Details) - $ / shares	3 Months Ended
	Nov. 30, 2024	Aug. 31, 2024
Class of Stock [Line Items]
Weighted average exercise price	$ 2.41
Series T [Member]
Class of Stock [Line Items]
Shares of common stock issuable from warrants outstanding	16,666,667	16,666,667
Weighted average exercise price	$ 1.70
Date of issuance	Nov. 26, 2018
Expiration	Nov. 26, 2029

Common Stock and Warrants (De_2

Common Stock and Warrants (Details Narrative) - $ / shares	Nov. 30, 2024	Aug. 31, 2024
Equity [Abstract]
Common stock, shares authorized	300,000,000	300,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares outstanding	53,198,399	53,198,399

Stock Options (Details)

Stock Options (Details)	3 Months Ended
	Nov. 30, 2024 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares subject to option grants, outstanding ending balance | shares	5,433,000
Weighted average exercise price, outstanding balance ending | $ / shares	$ 2.41
Weighted average remaining contractual term (years), outstanding	4 years 4 months 20 days
Number of shares subject to option grants, exercisable | shares	4,808,000
Weighted average exercise price, exercisable | $ / shares	$ 2.68
Equity Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares subject to option grants, outstanding beginning balance | shares	5,433,000
Weighted average exercise price, outstanding balance beginning | $ / shares	$ 2.41
Number of shares subject to option grants, outstanding ending balance | shares	5,433,000
Weighted average exercise price, outstanding balance ending | $ / shares	$ 2.41
Weighted average remaining contractual term (years), outstanding	4 years 4 months 20 days
Aggregate intrinsic value, outstanding | $
Number of shares subject to option grants, exercisable | shares	4,808,000
Weighted average exercise price, exercisable | $ / shares	$ 2.68
Weighted average remaining contractual term (years), exercisable	4 years 4 months 6 days
Aggregate intrinsic value, Exercisable | $

Stock Options (Details 1)

Stock Options (Details 1) - USD ($)	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Stock compensation expense:
Selling, general and administrative	$ 51,563	$ 22,510
Research and development		705
Total	$ 51,563	$ 23,215

Stock Options (Details 2)

Stock Options (Details 2)	3 Months Ended
	Nov. 30, 2024 $ / shares shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	5,433,000
Stock options outstanding, weighted average contractural life (years)	4 years 4 months 20 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 2.41
Stock options exercisable, number of shares subject to options exercise | shares	4,808,000
Stock options exercisable, weighted average remaining contractural life (Years)	4 years 4 months 6 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 2.68
$2.32 Per Share [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	1,250,000
Stock options outstanding, weighted average contractural life (years)	4 years 4 months 9 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 0.33
Stock options exercisable, number of shares subject to options exercise | shares	625,000
Stock options exercisable, weighted average remaining contractural life (Years)	4 years 4 months 9 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 0.33
Exercise Price Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	153,000
Stock options outstanding, weighted average contractural life (years)	4 years 10 months 9 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 2.32
Stock options exercisable, number of shares subject to options exercise | shares	153,000
Stock options exercisable, weighted average remaining contractural life (Years)	4 years 10 months 9 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 2.32
Exercise Price Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	2,500,000
Stock options outstanding, weighted average contractural life (years)	4 years 2 months 8 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 2.60
Stock options exercisable, number of shares subject to options exercise | shares	2,500,000
Stock options exercisable, weighted average remaining contractural life (Years)	4 years 2 months 8 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 2.60
Exercise Price Four [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	50,000
Stock options outstanding, weighted average contractural life (years)	1 year 10 months 17 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 3.42
Stock options exercisable, number of shares subject to options exercise | shares	50,000
Stock options exercisable, weighted average remaining contractural life (Years)	1 year 10 months 17 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 3.42
Exercise Price Five [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	35,000
Stock options outstanding, weighted average contractural life (years)	1 year 1 month 6 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 3.46
Stock options exercisable, number of shares subject to options exercise | shares	35,000
Stock options exercisable, weighted average remaining contractural life (Years)	1 year 1 month 6 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 3.46
Exercise Price Six [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	1,225,000
Stock options outstanding, weighted average contractural life (years)	3 years 7 months 13 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 3.54
Stock options exercisable, number of shares subject to options exercise | shares	1,225,000
Stock options exercisable, weighted average remaining contractural life (Years)	3 years 7 months 13 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 3.54
Exercise Price Seven [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	110,000
Stock options outstanding, weighted average contractural life (years)	3 years 11 months 19 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 4.87
Stock options exercisable, number of shares subject to options exercise | shares	110,000
Stock options exercisable, weighted average remaining contractural life (Years)	3 years 11 months 19 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 4.87
Exercise Price Eight [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options outstanding, number of shares subject to outstanding options | shares	110,000
Stock options outstanding, weighted average contractural life (years)	6 years 10 months 28 days
Stock options outstanding, weighted average exercise price | $ / shares	$ 6.21
Stock options exercisable, number of shares subject to options exercise | shares	110,000
Stock options exercisable, weighted average remaining contractural life (Years)	6 years 10 months 28 days
Stock options exercisable, weighted average exercise price | $ / shares	$ 6.21

Stock Options (Details Narrativ

Stock Options (Details Narrative) - Equity Option [Member]	Nov. 30, 2024 USD ($) $ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Closing stock option exercise price | $ / shares	$ 0.32
Option exercise price | $ / shares	$ 0.32
Aggregate intrinsic value of options vested | $	$ 0
Share based compensation expenses not yet recognized | $	$ 51,563

Transactions with Related Per_2

Transactions with Related Persons (Details Narrative) - USD ($)	3 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Related Party Transaction [Line Items]
Annual fee		$ 175,000
Legal service fee	$ 61,700	$ 43,750
Sierchio Law LLP [Member]
Related Party Transaction [Line Items]
Legal service fee	61,700
Related party payable	64,200
Board fee	$ 2,500